Literature DB >> 32792173

To Kill a Microglia: A Case for CSF1R Inhibitors.

Kim N Green1, Joshua D Crapser2, Lindsay A Hohsfield2.   

Abstract

Microglia, the brain's immune sentinels, have garnered much attention in recent years. Researchers have begun to identify the manifold roles that these cells play in the central nervous system (CNS), and this work has been greatly facilitated by microglial depletion paradigms. The varying degrees of spatiotemporal manipulation afforded by such techniques allow microglial ablation before, during, and/or following insult, injury, or disease. We review the major methods of microglial depletion, including toxin-based, genetic, and pharmacological approaches, which differ in key factors including depletion onset, duration, and off-target effects. We conclude that pharmacological CSF1R inhibitors afford the most extensive versatility in manipulating microglia, making them ideal candidates for future studies investigating microglial function in health and disease.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32792173      PMCID: PMC7484341          DOI: 10.1016/j.it.2020.07.001

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  129 in total

Review 1.  Microglia in steady state.

Authors:  Katrin Kierdorf; Marco Prinz
Journal:  J Clin Invest       Date:  2017-07-17       Impact factor: 14.808

2.  Layer V cortical neurons require microglial support for survival during postnatal development.

Authors:  Masaki Ueno; Yuki Fujita; Tatsuhide Tanaka; Yuka Nakamura; Junichi Kikuta; Masaru Ishii; Toshihide Yamashita
Journal:  Nat Neurosci       Date:  2013-03-24       Impact factor: 24.884

3.  Inducible control of gene expression with destabilized Cre.

Authors:  Richard Sando; Karsten Baumgaertel; Simon Pieraut; Nina Torabi-Rander; Thomas J Wandless; Mark Mayford; Anton Maximov
Journal:  Nat Methods       Date:  2013-09-22       Impact factor: 28.547

4.  Microglia contribute to normal myelinogenesis and to oligodendrocyte progenitor maintenance during adulthood.

Authors:  Nora Hagemeyer; Klara-Maria Hanft; Maria-Anna Akriditou; Nicole Unger; Eun S Park; E Richard Stanley; Ori Staszewski; Leda Dimou; Marco Prinz
Journal:  Acta Neuropathol       Date:  2017-07-06       Impact factor: 17.088

5.  Genetically induced brain inflammation by Cnp deletion transiently benefits from microglia depletion.

Authors:  Laura Fernandez Garcia-Agudo; Hana Janova; Lea E Sendler; Sahab Arinrad; Agnes A Steixner; Imam Hassouna; Evan Balmuth; Anja Ronnenberg; Nadine Schopf; Felicia J van der Flier; Martin Begemann; Henrik Martens; Martin S Weber; Susann Boretius; Klaus-Armin Nave; Hannelore Ehrenreich
Journal:  FASEB J       Date:  2019-05-15       Impact factor: 5.191

6.  Colony stimulating factor 1 receptor inhibition eliminates microglia and attenuates brain injury after intracerebral hemorrhage.

Authors:  Minshu Li; Zhiguo Li; Honglei Ren; Wei-Na Jin; Kristofer Wood; Qiang Liu; Kevin N Sheth; Fu-Dong Shi
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

7.  Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain.

Authors:  Maria I Fonseca; Shu-Hui Chu; Michael X Hernandez; Melody J Fang; Lila Modarresi; Pooja Selvan; Grant R MacGregor; Andrea J Tenner
Journal:  J Neuroinflammation       Date:  2017-03-06       Impact factor: 8.322

8.  Proximal recolonization by self-renewing microglia re-establishes microglial homeostasis in the adult mouse brain.

Authors:  Lihong Zhan; Grietje Krabbe; Fei Du; Ian Jones; Meredith C Reichert; Maria Telpoukhovskaia; Lay Kodama; Chao Wang; Seo-Hyun Cho; Faten Sayed; Yaqiao Li; David Le; Yungui Zhou; Yin Shen; Brian West; Li Gan
Journal:  PLoS Biol       Date:  2019-02-08       Impact factor: 8.029

9.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.

Authors:  J C Lambert; C A Ibrahim-Verbaas; D Harold; A C Naj; R Sims; C Bellenguez; A L DeStafano; J C Bis; G W Beecham; B Grenier-Boley; G Russo; T A Thorton-Wells; N Jones; A V Smith; V Chouraki; C Thomas; M A Ikram; D Zelenika; B N Vardarajan; Y Kamatani; C F Lin; A Gerrish; H Schmidt; B Kunkle; M L Dunstan; A Ruiz; M T Bihoreau; S H Choi; C Reitz; F Pasquier; C Cruchaga; D Craig; N Amin; C Berr; O L Lopez; P L De Jager; V Deramecourt; J A Johnston; D Evans; S Lovestone; L Letenneur; F J Morón; D C Rubinsztein; G Eiriksdottir; K Sleegers; A M Goate; N Fiévet; M W Huentelman; M Gill; K Brown; M I Kamboh; L Keller; P Barberger-Gateau; B McGuiness; E B Larson; R Green; A J Myers; C Dufouil; S Todd; D Wallon; S Love; E Rogaeva; J Gallacher; P St George-Hyslop; J Clarimon; A Lleo; A Bayer; D W Tsuang; L Yu; M Tsolaki; P Bossù; G Spalletta; P Proitsi; J Collinge; S Sorbi; F Sanchez-Garcia; N C Fox; J Hardy; M C Deniz Naranjo; P Bosco; R Clarke; C Brayne; D Galimberti; M Mancuso; F Matthews; S Moebus; P Mecocci; M Del Zompo; W Maier; H Hampel; A Pilotto; M Bullido; F Panza; P Caffarra; B Nacmias; J R Gilbert; M Mayhaus; L Lannefelt; H Hakonarson; S Pichler; M M Carrasquillo; M Ingelsson; D Beekly; V Alvarez; F Zou; O Valladares; S G Younkin; E Coto; K L Hamilton-Nelson; W Gu; C Razquin; P Pastor; I Mateo; M J Owen; K M Faber; P V Jonsson; O Combarros; M C O'Donovan; L B Cantwell; H Soininen; D Blacker; S Mead; T H Mosley; D A Bennett; T B Harris; L Fratiglioni; C Holmes; R F de Bruijn; P Passmore; T J Montine; K Bettens; J I Rotter; A Brice; K Morgan; T M Foroud; W A Kukull; D Hannequin; J F Powell; M A Nalls; K Ritchie; K L Lunetta; J S Kauwe; E Boerwinkle; M Riemenschneider; M Boada; M Hiltuenen; E R Martin; R Schmidt; D Rujescu; L S Wang; J F Dartigues; R Mayeux; C Tzourio; A Hofman; M M Nöthen; C Graff; B M Psaty; L Jones; J L Haines; P A Holmans; M Lathrop; M A Pericak-Vance; L J Launer; L A Farrer; C M van Duijn; C Van Broeckhoven; V Moskvina; S Seshadri; J Williams; G D Schellenberg; P Amouyel
Journal:  Nat Genet       Date:  2013-10-27       Impact factor: 38.330

10.  Targeting macrophage and microglia activation with colony stimulating factor 1 receptor inhibitor is an effective strategy to treat injury-triggered neuropathic pain.

Authors:  SeungHwan Lee; Xiang Qun Shi; Anni Fan; Brian West; Ji Zhang
Journal:  Mol Pain       Date:  2018 Jan-Dec       Impact factor: 3.395

View more
  34 in total

Review 1.  Microglia in CNS infections: insights from Toxoplasma gondii and other pathogens.

Authors:  Maureen N Cowan; Ish Sethi; Tajie H Harris
Journal:  Trends Parasitol       Date:  2022-01-14

2.  Microglial depletion and abnormalities in gut microbiota composition and short-chain fatty acids in mice after repeated administration of colony stimulating factor 1 receptor inhibitor PLX5622.

Authors:  Yong Yang; Tamaki Ishima; Xiayun Wan; Yan Wei; Lijia Chang; Jiancheng Zhang; Youge Qu; Kenji Hashimoto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-09-04       Impact factor: 5.270

Review 3.  Diversity and Function of Glial Cell Types in Multiple Sclerosis.

Authors:  Lucas Schirmer; Dorothy P Schafer; Theresa Bartels; David H Rowitch; Peter A Calabresi
Journal:  Trends Immunol       Date:  2021-02-13       Impact factor: 16.687

4.  Atg7 deficiency in microglia drives an altered transcriptomic profile associated with an impaired neuroinflammatory response.

Authors:  Lara Friess; Mathilde Cheray; Lily Keane; Kathleen Grabert; Bertrand Joseph
Journal:  Mol Brain       Date:  2021-06-03       Impact factor: 4.041

Review 5.  White matter microglia heterogeneity in the CNS.

Authors:  Sandra Amor; Niamh B McNamara; Emma Gerrits; Manuel C Marzin; Susanne M Kooistra; Veronique E Miron; Erik Nutma
Journal:  Acta Neuropathol       Date:  2021-12-08       Impact factor: 17.088

Review 6.  Small molecule therapeutics for neuroinflammation-mediated neurodegenerative disorders.

Authors:  Silke Miller; Maria-Jesus Blanco
Journal:  RSC Med Chem       Date:  2021-04-13

7.  Microglia Elimination Increases Neural Circuit Connectivity and Activity in Adult Mouse Cortex.

Authors:  Yong-Jun Liu; Elizabeth E Spangenberg; Bryan Tang; Todd C Holmes; Kim N Green; Xiangmin Xu
Journal:  J Neurosci       Date:  2020-12-30       Impact factor: 6.167

8.  Targeting neutrophils as a novel therapeutic strategy after stroke.

Authors:  Chen Chen; Tingting Huang; Xiaozhu Zhai; Yezhi Ma; Lv Xie; Bingwei Lu; Yueman Zhang; Yan Li; Zengai Chen; Jiemin Yin; Peiying Li
Journal:  J Cereb Blood Flow Metab       Date:  2021-03-10       Impact factor: 6.200

9.  CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia.

Authors:  Chritica Lodder; Isabelle Scheyltjens; Ilie Cosmin Stancu; Kiavash Movahedi; Ilse Dewachter; Pablo Botella Lucena; Manuel Gutiérrez de Ravé; Sarah Vanherle; Tim Vanmierlo; Niels Cremers; Hannah Vanrusselt; Bert Brône; Bernard Hanseeuw; Jean-Noël Octave; Astrid Bottelbergs
Journal:  Acta Neuropathol Commun       Date:  2021-06-08       Impact factor: 7.801

Review 10.  Modeling CSF-1 receptor deficiency diseases - how close are we?

Authors:  Violeta Chitu; Şölen Gökhan; E Richard Stanley
Journal:  FEBS J       Date:  2021-07-05       Impact factor: 5.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.